Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
暂无分享,去创建一个
[1] 竹田 昌彦. Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression , 2018 .
[2] Manran Liu,et al. Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression. , 2015, Cancer letters.
[3] V. Heinemann,et al. Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial , 2015, BMC Cancer.
[4] T. Kalber,et al. Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors , 2015, The Journal of Immunology.
[5] A. Gemma,et al. Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth , 2015, Oncotarget.
[6] W. Woodward,et al. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model , 2015, Breast Cancer Research.
[7] Stephen T. C. Wong,et al. Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model. , 2015, Cell reports.
[8] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[9] G. Inghirami,et al. Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.
[10] M. Bhasin,et al. MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. , 2014, Cell stem cell.
[11] N. Cho,et al. Cancer‐associated fibroblast promote transmigration through endothelial brain cells in three‐dimensional in vitro models , 2014, International journal of cancer.
[12] Jun Chen,et al. Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications. , 2014, Cancer letters.
[13] R. Weinberg,et al. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis , 2014, Nature Cell Biology.
[14] P. Rameshwar,et al. Treg/Th17 polarization by distinct subsets of breast cancer cells is dictated by the interaction with mesenchymal stem cells. , 2014, Journal of cancer stem cell research.
[15] J. Bouchal,et al. The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance , 2014, Cancer Cell International.
[16] J. Rak,et al. Genetic Basis of Thrombosis in Cancer , 2014, Seminars in Thrombosis & Hemostasis.
[17] J. Kurtzberg,et al. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] A. Godwin,et al. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion , 2013, Proceedings of the National Academy of Sciences.
[19] Feng Yu,et al. A Vaccine That Co-Targets Tumor Cells and Cancer Associated Fibroblasts Results in Enhanced Antitumor Activity by Inducing Antigen Spreading , 2013, PloS one.
[20] S. Kaul,et al. Mortalin antibody-conjugated quantum dot transfer from human mesenchymal stromal cells to breast cancer cells requires cell-cell interaction. , 2013, Experimental cell research.
[21] B. Niederle,et al. Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis , 2013, Virchows Archiv.
[22] C. Verfaillie,et al. Mesenchymal Stem Cells Migration Homing and Tracking , 2013, Stem cells international.
[23] S. Corso,et al. Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective. , 2013, Cancer discovery.
[24] R. Stahel,et al. Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells , 2013, Journal of Translational Medicine.
[25] A. Schambach,et al. Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo. , 2013, Stem cells and development.
[26] A. Soricelli,et al. Brief Report: Mesenchymal Stromal Cell Atrophy in Coculture Increases Aggressiveness of Transformed Cells , 2013, Stem cells.
[27] J. Wrana,et al. Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration , 2012, Cell.
[28] Kunwei Shen,et al. Stromal cells in tumor microenvironment and breast cancer , 2012, Cancer and Metastasis Reviews.
[29] King-Jen Chang,et al. Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway. , 2012, Cancer research.
[30] G. van der Pluijm,et al. Epithelial Plasticity, Cancer Stem Cells, and the Tumor-Supportive Stroma in Bladder Carcinoma , 2012, Molecular Cancer Research.
[31] H. Haller,et al. Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. , 2012, Stem cells and development.
[32] G. Rappa,et al. Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. , 2012, The American journal of pathology.
[33] G. Fishman,et al. Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells , 2012, Proceedings of the National Academy of Sciences.
[34] E. Vairaktaris,et al. The interplay between hemostasis and malignancy: the oral cancer paradigm. , 2012, Anticancer research.
[35] D. Banerjee,et al. Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion , 2012, PloS one.
[36] S. Richardson,et al. Bi-Directional Exchange of Membrane Components Occurs during Co-Culture of Mesenchymal Stem Cells and Nucleus Pulposus Cells , 2012, PloS one.
[37] H. Dvorak,et al. Vascular hyperpermeability, angiogenesis, and stroma generation. , 2012, Cold Spring Harbor perspectives in medicine.
[38] C. Kunder,et al. Mast cell modulation of the vascular and lymphatic endothelium. , 2011, Blood.
[39] Kathleen R. Cho,et al. Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. , 2011, The Journal of clinical investigation.
[40] H. Dvorak,et al. Orphan nuclear transcription factor TR3/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctions , 2011, Proceedings of the National Academy of Sciences.
[41] A. Jimeno,et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy , 2011, Nature Medicine.
[42] B. Niederle,et al. Desmoplastic stromal reaction in papillary thyroid microcarcinoma , 2011, Histopathology.
[43] Andreas Trumpp,et al. Bridging the information gap , 2011, Nature Immunology.
[44] Steven J. Greco,et al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.
[45] X.L. Lu,et al. α-Tocopherol Treatment Ameliorates Chronic Pancreatitis in an Experimental Rat Model Induced by Trinitrobenzene Sulfonic Acid , 2011, Pancreatology.
[46] G. Dontu,et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. , 2011, Cancer research.
[47] M. Andreeff,et al. Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.
[48] W. Woodward,et al. Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells , 2010, PloS one.
[49] A. Vincent-Salomon,et al. Oxidative stress promotes myofibroblast differentiation and tumour spreading , 2010, EMBO molecular medicine.
[50] F. Baron,et al. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[51] Ruth S. Waterman,et al. A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.
[52] J. Seoane,et al. Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis. , 2009, Experimental cell research.
[53] M. Andreeff,et al. Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.
[54] Eric S. Lander,et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.
[55] K. Burridge,et al. The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species* , 2009, The Journal of Biological Chemistry.
[56] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[57] A. Gemma,et al. Clinicopathological analysis of primary lung carcinoma with heterotopic ossification. , 2009, Lung cancer.
[58] A. Kate Sasser,et al. Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.
[59] M. Stella,et al. The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis. , 2008, Molecular biology of the cell.
[60] R. Cardiff,et al. SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. , 2008, Cancer research.
[61] J. Gilabert-Estellés,et al. Fibrinolysis: the key to new pathogenetic mechanisms. , 2008, Current medicinal chemistry.
[62] W. Woodward,et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. , 2007, Cancer research.
[63] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[64] C. Haslinger,et al. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. , 2007, International journal of oncology.
[65] E. Lam,et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth , 2007, Leukemia.
[66] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[67] R. Reed,et al. Inhibition of carcinoma cell‐derived VEGF reduces inflammatory characteristics in xenograft carcinoma , 2006, International journal of cancer.
[68] M. Loeffler,et al. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.
[69] Lindolfo da Silva Meirelles,et al. Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.
[70] K. Kaczirek,et al. Desmoplastic Stromal Reaction in Medullary Thyroid Cancer—An Intraoperative “Marker” for Lymph Node Metastases , 2006, World Journal of Surgery.
[71] R. Jain,et al. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. , 2006, Blood.
[72] Darwin J. Prockop,et al. Mitochondrial transfer between cells can rescue aerobic respiration , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[73] A. Gansmuller,et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. , 2005, Cancer research.
[74] E. Gilboa,et al. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. , 2005, Cancer research.
[75] C. Dermardirossian,et al. GDIs: central regulatory molecules in Rho GTPase activation. , 2005, Trends in cell biology.
[76] Andrea Bacigalupo,et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[77] V. Pellegrini,et al. The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: An animal model in the rabbit , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[78] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[79] K. Ohuchida,et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. , 2004, Cancer research.
[80] Y. Rao,et al. Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.
[81] Xiaochong Wu,et al. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. , 2003, Cancer research.
[82] S. Larson,et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[83] T. Joh,et al. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. , 2003, Gastroenterology.
[84] D. Jäger,et al. Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer , 2003, Oncology Research and Treatment.
[85] G. Ayala,et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[86] M. Andreeff,et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.
[87] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[88] S. Rafii,et al. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.
[89] K. Pfizenmaier,et al. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas , 2001, International journal of cancer.
[90] R K Jain,et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[91] J. Little,et al. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[92] G. Beatty,et al. IFN-γ Can Promote Tumor Evasion of the Immune System In Vivo by Down-Regulating Cellular Levels of an Endogenous Tumor Antigen1 , 2000, The Journal of Immunology.
[93] H. Geuze,et al. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.
[94] A. Jackson,et al. Induction of microsatellite instability by oxidative DNA damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[95] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[96] J. Foekens,et al. Stromal influences on breast cancer cell growth. , 1992, British Journal of Cancer.
[97] V. Bertone,et al. Stroma formation in Ehrlich carcinoma. I. Oedema phase. A mitosis burst as an index of physiological reoxygenation? , 1991, Anticancer research.
[98] D. McKay. [3H]Noradrenaline accumulation in cultured bovine adrenal medullary cells: modulation of accumulation by nicotine , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.
[99] D. McEachern,et al. Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts. , 1989, Cancer research.
[100] H. Dvorak,et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. , 1989, Biochimica et biophysica acta.
[101] H. Dvorak,et al. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[102] D. Zipori,et al. Stromal cell effects on clonal growth of tumors , 1987, Cancer.
[103] A Ahmed,et al. Stromal changes in invasive breast carcinoma: An ultrastructural study , 1987, The Journal of pathology.
[104] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[105] K. Mann,et al. Tumor cell generation of thrombin via functional prothrombinase assembly. , 1985, Cancer research.
[106] Gary R. Grotendorst,et al. Increased content of Type V Collagen in desmoplasia of human breast carcinoma. , 1982, The American journal of pathology.
[107] E. Manseau,et al. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. , 1979, Journal of the National Cancer Institute.
[108] H. Dvorak,et al. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. , 1979, Journal of immunology.
[109] J. Papadimitriou,et al. The effect of inflammatory stimuli on the stroma of neoplasms: The involvement of mononuclear phagocytes , 1977, The Journal of pathology.
[110] H. Lazarus,et al. GROWTH CHARACTERISTICS OF VIRUS-TRANSFORMED CELLS , 1970, The Journal of experimental medicine.
[111] M. Greenblatt,et al. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. , 1968, Journal of the National Cancer Institute.
[112] I. Levin. THE MECHANISMS OF METASTASIS FORMATION IN EXPERIMENTAL CANCER , 1913, The Journal of experimental medicine.
[113] I. Levin. CHANGES IN THE TISSUE SURROUNDING A GROWING TUMOR AND THE SIGNIFICANCE OF THE "PRECANCEROUS STATE." , 1912, The Journal of experimental medicine.
[114] E. R. Le Count. LYMPHOMA, A BENIGN TUMOR REPRESENTING A LYMPH GLAND IN STRUCTURE , 1899, The Journal of experimental medicine.
[115] P. Rameshwar,et al. Treg / Th 17 polarization by distinct subsets of breast cancer cells is dictated by the interaction with mesenchymal stem cells , 2014 .
[116] M. McNiven. Breaking away: matrix remodeling from the leading edge. , 2013, Trends in cell biology.
[117] Kenneth M. Yamada,et al. Direct visualization of protease activity on cells migrating in three-dimensions. , 2009, Matrix Biology.
[118] J. Wagner,et al. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial , 2009, Bone Marrow Transplantation.
[119] P. Gumerlock,et al. Molecular biology of prostate cancer , 2004, World Journal of Urology.
[120] 久野 篤. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats , 2004 .
[121] J. Ringel,et al. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. , 2001, Cancer research.
[122] J. Ringel,et al. Transforming Growth Factor-β1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma , 2001 .
[123] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[124] F. Jänicke,et al. Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. , 1992, Biological chemistry Hoppe-Seyler.
[125] M. Abercrombie. The bases of the locomotory behaviour of fibroblasts. , 1961, Experimental cell research.